BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11579507)

  • 1. [Successful second transplant from one-locus HLA-mismatched unrelated donor for graft rejection following initial transplant from another unrelated donor in a patient with chronic myelogenous leukemia].
    Tanaka M; Kanamori H; Kuwabara H; Yamaji S; Kamijo A; Taguchi J; Fujita H; Fujisawa S; Matsuzaki M; Mohri H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Aug; 42(8):656-8. PubMed ID: 11579507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT.
    Byrne JL; Musuka C; Davy B; Donovan L; Russell NH
    Bone Marrow Transplant; 2001 Mar; 27(5):547-9. PubMed ID: 11313691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A; Amar A; Brautbar C; Condiotti R; Lazarovitz V; Nagler A
    Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
    Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for chronic myelogenous leukemia in blastic phase using a phenotypically identical unrelated volunteer donor. Nagoya Bone Marrow Transplantation Group (NBMTG), Tokai Marrow Donor Bank (TMDB).
    Akatsuka Y; Kodera Y; Yamamoto K; Minami S; Miyamura K; Morishita Y; Morishima Y; Saitoh H; Horibe K; Yamauchi T
    Int J Hematol; 1992 Jun; 55(3):249-53. PubMed ID: 1498315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second unrelated bone marrow transplantation without additional conditioning therapy after engraftment failure.
    Wolff D; Becker C; Kubel M; Pönisch W; Edelmann J; Friedrich T; Helbig W
    Bone Marrow Transplant; 1998 Feb; 21(3):315-7. PubMed ID: 9489660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.
    Schultz KR; Ratanatharathorn V; Abella E; Eisenbrey AB; Karanes C; Lum LG; de Planque MM; Uberti JP; Ravindranath Y; Sensenbrenner LL
    Bone Marrow Transplant; 1994 Jun; 13(6):817-22. PubMed ID: 7920320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
    Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML): treatment with a second BMT.
    Gil-Fernández JJ; Arranz R; Cámara R; Alegre A; Figuera A; Fernández-Rañada JM
    Haematologica; 1998 Mar; 83(3):285-7. PubMed ID: 9580418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FK506 for the prophylaxis of graft-versus-host-disease after bone marrow transplantation from HLA-genotypically mismatched unrelated donor].
    Nishida T; Haneda M; Kanie T; Murata M; Hamaguchi M; Minami S; Kodera Y
    Rinsho Ketsueki; 1998 Aug; 39(8):574-9. PubMed ID: 9785975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Result of allogeneic bone marrow transplantation from unrelated donor].
    Yabe H; Kato S
    Rinsho Ketsueki; 1990 May; 31(5):614-9. PubMed ID: 2395212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
    Teshima T; Matsuo K; Matsue K; Kawano F; Taniguchi S; Hara M; Hatanaka K; Tanimoto M; Harada M; Nakao S; Abe Y; Wake A; Eto T; Takemoto Y; Imamura M; Takahashi S; Ishida Y; Kanda Y; Kasai M; Takaue Y
    Br J Haematol; 2005 Aug; 130(4):575-87. PubMed ID: 16098073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transplantation of bone marrow from unrelated donors in chronic myeloid leukemia].
    Ehninger G; Dopfer R; Einsele H; Schmidt H; Jaschonek KG; Haen M; Pawelec G; Schneider W; Grosse-Wilde H; Rutayungwa ET
    Dtsch Med Wochenschr; 1989 Jun; 114(25):986-8. PubMed ID: 2661185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of acute bone marrow graft rejection in T cell-depleted, partially mismatched related donor bone marrow transplantation.
    Lamb LS; Szafer F; Henslee-Downey PJ; Walker M; King S; Godder K; Pati AR; Best R; Steinman L; Geier SS
    Exp Hematol; 1995 Dec; 23(14):1595-600. PubMed ID: 8542952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Hetero to homo" allogeneic bone marrow transplantation from a related donor with two HLA loci mismatch].
    Kawano R; Kimura M; Noguchi Y; Goto T; Takatsuki H; Yufu Y; Uike N
    Rinsho Ketsueki; 2000 Sep; 41(9):761-3. PubMed ID: 11070940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Second transplant from the same donor without conditioning for bone marrow aplasia after non-myeloablative hematopoietic stem cell transplantation for chronic myeloid leukemia].
    Ishikawa I; Miyamura K; Yamada M; Sasaki O; Harigae H; Kameoka J; Meguro K; Sasaki T
    Rinsho Ketsueki; 2005 Dec; 46(12):1288-92. PubMed ID: 16447801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.